» Articles » PMID: 25370599

Worsening of Renal Function During 1 Year After Hospital Discharge is a Strong and Independent Predictor of All-cause Mortality in Acute Decompensated Heart Failure

Abstract

Background: Renal impairment is a common comorbidity and the strongest risk factor for poor prognosis in acute decompensated heart failure (ADHF). In clinical practice, renal function is labile during episodes of ADHF, and often worsens after discharge. The significance of worsening of renal function (WRF) after discharge has not been investigated as extensively as baseline renal function at admission or WRF during hospitalization.

Methods And Results: Among 611 consecutive patients with ADHF emergently admitted to our hospital, 233 patients with 3 measurements of serum creatinine (SCr) level measurements (on admission, at discharge, and 1 year after discharge) were included in the present study. Patients were divided into 2 groups according to the presence or absence of WRF at 1 year after discharge (1y-WRF), defined as an absolute increase in SCr >0.3 mg/dL (>26.5 μmol/L) plus a ≥25% increase in SCr at 1 year after discharge compared to the SCr value at discharge. All-cause and cardiovascular mortality were assessed as adverse outcomes. During a mean follow-up of 35.4 months, 1y-WRF occurred in 48 of 233 patients. There were 66 deaths from all causes. All-cause and cardiovascular mortality were significantly higher in patients with 1y-WRF (log-rank P<0.0001 and P<0.0001, respectively) according to Kaplan-Meier analysis. In a multivariate Cox proportional hazards model, 1y-WRF was a strong and independent predictor of all-cause and cardiovascular mortality. Hemoglobin and B-type natriuretic peptide at discharge, as well as left ventricular ejection fraction <50%, were independent predictors of 1y-WRF.

Conclusions: In patients with ADHF, 1y-WRF is a strong predictor of all-cause and cardiovascular mortality.

Citing Articles

Impact of kidney volume on incidence of in-hospital kidney-related adverse outcomes in patients with acute heart failure.

Saito A, Asano T, Komiyama N, Ohde S BMC Cardiovasc Disord. 2025; 25(1):60.

PMID: 39875830 PMC: 11776214. DOI: 10.1186/s12872-025-04502-4.


Worsening renal function in hospitalized patients with systolic heart failure: prevalence and risk factors.

Ghafouri Asbagh A, Taban Sadeghi M, Ramazanilar P, Nateghian H ESC Heart Fail. 2023; 10(5):2837-2842.

PMID: 37408169 PMC: 10567670. DOI: 10.1002/ehf2.14463.


The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study.

Venegas-Rodriguez A, Pello A, Lopez-Castillo M, Urquia M, Balaguer-German J, Munte A ESC Heart Fail. 2023; 10(4):2418-2426.

PMID: 37226407 PMC: 10375164. DOI: 10.1002/ehf2.14398.


New Classification for the Combined Assessment of the Fractional Excretion of Urea Nitrogen and Estimated Plasma Volume Status in Acute Heart Failure.

Nogi K, Ueda T, Nakamura T, Nogi M, Ishihara S, Nakada Y J Am Heart Assoc. 2022; 12(1):e025596.

PMID: 36583422 PMC: 9973588. DOI: 10.1161/JAHA.122.025596.


Validation and derivation of short-term prognostic risk score in acute decompensated heart failure in China.

Zhao H, Gao X, Liu Y, Li S, Zhang Q, Shan W BMC Cardiovasc Disord. 2022; 22(1):307.

PMID: 35799104 PMC: 9264535. DOI: 10.1186/s12872-022-02743-1.


References
1.
Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R . Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail. 2008; 10(2):188-95. DOI: 10.1016/j.ejheart.2008.01.011. View

2.
Hillege H, Nitsch D, Pfeffer M, Swedberg K, McMurray J, Yusuf S . Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113(5):671-8. DOI: 10.1161/CIRCULATIONAHA.105.580506. View

3.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K . Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53(6):982-92. DOI: 10.1053/j.ajkd.2008.12.034. View

4.
Diez J, Coca A, de Teresa E, Anguita M, Castro-Beiras A, Conthe P . TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. Expert Rev Cardiovasc Ther. 2009; 7(8):897-904. DOI: 10.1586/erc.09.74. View

5.
Damman K, Jaarsma T, Voors A, Navis G, Hillege H, Van Veldhuisen D . Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail. 2009; 11(9):847-54. DOI: 10.1093/eurjhf/hfp108. View